Vivos Therapeutics, Inc.
Vivos Therapeutics, Inc.（VVOS）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
vvos · 股价预测 · 5 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 5 位华尔街分析师
Buy
5 位分析师
共识
评级分布
12 个月目标价
High
$2.50
Consensus
$2.13
+144.8% upside
Low
$1.75
Median: $2.125 · Last Close: $0.87
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$2.13
144.8% upside
High Target
$2.5
187.4%
Low Target
$1.75
101.1%
Current Price
$0.87
as of today
Based on analyst price targets, the VVOS stock price prediction for the next 12 months ranges from $1.75 to $2.5. The consensus VVOS price forecast of $2.13 implies 144.8% upside from the current price of $0.87.
短期股价预测
Bear算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $0.91 | ↑ 5.00% |
1-day model range: $0.9–$0.93. Peak: $0.93 (+5.00%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $0 | -50.0% |
| 2028 | $0 | -62.5% |
| 2029 | $0 | -67.2% |
| 2030 | $0 | -69.2% |
| 2031 | — | -70.2% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · VVOS · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-06-04 | Ascendiant Capital | Maintains | Buy→Buy |
| 2026-04-22 | Ascendiant Capital | Maintains | Buy→Buy |
| 2026-04-17 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-12-03 | Ascendiant Capital | Maintains | Buy→Buy |
| 2025-09-09 | Ascendiant Capital | Maintains | Buy→Buy |
| 2025-04-15 | Ascendiant Capital | Maintains | Buy→Buy |
| 2024-11-20 | Ascendiant Capital | Maintains | Buy→Buy |
| 2024-11-19 | Alliance Global Partners | Maintains | Buy→Buy |
| 2024-08-20 | Ascendiant Capital | Maintains | Buy→Buy |
| 2023-01-17 | Ascendiant Capital | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Vivos Therapeutics, Inc. (VVOS) stock. Of the recent 14 rating actions, 0 were upgrades and 0 were downgrades. 5 analysts currently cover VVOS.
分析师推荐趋势
VVOS analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$14M
↓ 32.3% YoY
Revenue Next Year
$15M
↑ 8.4% YoY
EPS This Year
$-5.91
EPS Next Year
$-2.02
↓ 65.8% YoY
EPS ForecastReported vs Estimated
Analysts forecast VVOS EPS of $-5.91 for the current fiscal year, based on estimates from 1 analysts. The VVOS revenue forecast is $14M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
VVOS 股价预测由两类独立数据源支撑：来自 5 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。VVOS 的共识目标价为 $2.13（+144.8% 上行空间），分析师共识为 Buy。
VVOS 的短期预测（明日）为 $0.91（+5.00%）。 VVOS 对 2027 年的股价预测均值为 $0。 VVOS 对 2030 年的预测区间为 $0–$0。
Vivos Therapeutics, Inc. 在 NASDAQ 上市，代码 VVOS。VVOS 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
VVOS 预测 · 8 个问题根据 5 位华尔街分析师，VVOS 的 12 个月平均目标价为 $2.13，最高 $2.50、最低 $1.75。若有图表，中位目标价可在上方查看。相对当前价 $0.87，隐含约 +144.8% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.